The logo of Danish pharmaceutical company Novo Nordisk at their headquarters in Bagsvaerd, Denmark, on Feb. 1, 2017. Liselotte Sabroe/Scanpix Denmark/AFP via Getty ImagesNovo Nordisk, the Denmark-based Ozempic creator, has launched a bidding war with Pfizer Inc. to acquire New York-based Metsera Inc.Founded in 2022, Metsera is a clinical-stage biopharmaceutical firm specializing in treatments for obesity and metabolic diseases.
Date:
More like thisRelated
Soybeans, Rare Earths, Fentanyl: 9 Takeaways From Trumps Meeting With Xi
U.S. President Donald Trump and Chinese leader Xi Jinping...
Ford Recalls 227,000 Vehicles Over Seat, Defrosting System, Windshield Air Bubble Issues
Ford offers rides in the 2022 Bronco Sport on...
China Approved TikTok Transfer Deal, Bessent Says
A TikTok building in Culver City, Calif., on March...
Fed Cuts Interest Rates AgainWhat This Means for Your Money
The Federal Reserve might hold off on a December...
